PARP inhibitors (Inotek)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePARP inhibitors (Inotek)

Drug Alias NamePARP inhibitors (Inotek)Poly polymerase inhibitor (Inotek)Poly polymerase inhibitor (Inotek)PARP inhibitor (Inotek)PARP inhibitors (Inotek) +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors

TargetsPoly (ADP-Ribose) polymerase

Therapy Area/IndicationsIschemiaInflammationDiabetes Mellitus +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRocket Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRocket Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsIschemiaInflammationDiabetes Mellitus +[7]

Other Information

ATC CodeN/A